Skandinaviska Enskilda Banken (SEB)’s CONMED CNMD Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,226	Closed	-$309K	–	923
2022 Q2	$309K	Sell	3,226 -1,548	-32%	-$186K	﹤0.01%	856
2022 Q1	$709K	Sell	4,774 -2,368	-33%	-$331K	﹤0.01%	800
2021 Q4	$1.02M	Hold	7,142	–	–	0.01%	767
2021 Q3	$934K	Sell	7,142 -1,367	-16%	-$179K	0.01%	797
2021 Q2	$1.17M	Buy	8,509 +264	+3%	+$36.1K	0.01%	788
2021 Q1	$1.08M	Buy	8,245 +488	+6%	+$58.7K	0.01%	810
2020 Q4	$869K	Buy	7,757 +2,183	+39%	+$207K	0.01%	838
2020 Q3	$439K	Buy	5,574 +5,448	+4,324%	+$444K	﹤0.01%	843
2020 Q2	$9K	Buy	+126	New	+$8.77K	﹤0.01%	1041

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s CNMD Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of CONMED (CNMD) in Q3 2022, closing a stake of 3,226 shares — an estimated $309K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CNMD in Q2 2020 and held it in 9 quarters. The position peaked at $1.17M in Q2 2021. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

Skandinaviska Enskilda Banken (SEB) reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 3,226 CONMED shares in Q3 2022, an estimated $309K.
Skandinaviska Enskilda Banken (SEB) first reported a position in CONMED in Q2 2020 and held it in 9 quarters.
Skandinaviska Enskilda Banken (SEB)'s CONMED position peaked at $1.17M in Q2 2021.
252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.